Corticotropin releasing factor antagonist, α-helical CRF9-41, reverses nicotine-induced conditioned, but not unconditioned, anxiety

Psychopharmacology

Volumn 167, Issue 3, 2003, Pages 251-256

  Tucci, Sonia ^a   Cheeta, Survjit ^a,b   Seth, Pallab ^a   File, Sandra E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Dept Addictive Behaviour/P ^*  (United Kingdom)

Author keywords

Conditioned anxiety; CRF; Nicotine; Social interaction; Unconditioned anxiety; Helical CRF9 41

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; NICOTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

EID: 0038174672     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1403-4     Document Type: Article

References (51)

1. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT (1991) CRF antagonist reverses the anxiogenic response to ethanol withdrawal in the rat. Psychopharmacology 103:227-232
2. Basso AM, Spina M, Rivier J, Vale W, Koob GF (1999) Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology 145:21-30
3. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, Carr K, Hall S (1996) Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347:504-508
4. Brioni JD, O'Neill AB, Kim DJ, Decker MW (1993) Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 238:1-8
5. Costall B, Kelly ME, Naylor RJ, Onaivi ES (1989) The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol Biochem Behav 33:197-203
6. DeVries AC, Pert A (1998) Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor. Psychopharmacology 137:333-340
7. Dunn AJ, File SE (1987) Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm Behav 21:193-202
8. Dunn AJ, Berridge CW (1990a) Is corticotropin-releasing factor a mediator of stress responses? Ann NY Acad Sci 579:183-191
9. Dunn AJ, Berridge CW (1990b) Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 156:71-100
10. Field M, Duka T (2001) Smoking expectancy mediates the conditioned responses to arbitrary smoking cues. Behav Pharmacol 12:183-194
11. File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 2:219-238
12. File SE, Hyde JRG (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19-24
13. File SE, Seth P (2003) A review of 25 years of the social interaction test. Eur J Pharmacol 463:35-53
14. File SE, Kenny PJ, Ouagazzal AM (1998) Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav Neurosci 112:1423-1429
15. File SE, Cheeta S, Kenny PJ (2000) Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur J Pharmacol 393:231-236
16. File SE, Fluck E, Leahy A (2001a) Nicotine has calming effects on stress-induced mood changes in females, but enhances aggressive mood in males. Int J Neuropsychopharmacol 4:371-376
17. File S, Irvine E, Cheeta S, Akhtar M, Tucci S, Seth P (2001b) Nicotine and conditioned anxiety. Soc Neurosci Abstr 27:222.11
18. File SE, Cheeta S, Irvine E, Tucci S, Akthar M (2002) Conditioned anxiety to nicotine. Psychopharmacology 164:309-317
19. Fudala PJ, Teoh KW, Iwamoto ET (1985) Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol Biochem Behav 22:237-241
20. Heinrichs SC, Menzaghi F, Pich EM, Baldwin HA, Rassnick S, Britton KT, Koob GF (1994) Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology 11:179-186
21. Heinrichs SC, Stenzel-Poore MP, Gold LH, Battenberg E, Bloom FE, Koob GF, Vale WW, Pich EM (1996) Learning impairment in transgenic mice with central overexpression of corticotropin releasing factor. Neuroscience 74:303-311
22. Hillhouse EW, Milton NG (1989) Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. J Endocrinol 122:713-718
23. Hunt WA, Barnett LW, Branch LG (1971) Relapse rates in addiction programs. J Clin Psychol 27:455-456
24. Ikard FF, Green DE, Horn D (1969) A scale differentiates between types of smoking as related to the management of affect. Int J Addict 4:649-659
25. Irvine E, Cheeta S, File SE (1999) Time course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol 10:691-697
26. Karanth S, Lyson K, McCann SM (1999) Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus. Neuroimmunomodulation 6:168-174
27. Kasckow JW, Regmi A, Sheriff S, Mulchahey J, Geracioti TD Jr (1999) Regulation of corticotropin-releasing factor messenger RNA by nicotine in an immortalized amygdalar cell line. Life Sci 65:2709-2714
28. Kikusui T, Takeuchi Y, Mori Y (2000) Involvement of corticotropin-releasing factor in the retrieval process of fear-conditioned ultrasonic vocalisation in rats. Physiol Behav 71:323-328
29. Koob GF, Bloom FE (1985) Corticotropin-releasing factor and behavior. Fed Proc 44:259-263
30. Kumar KB, Karanth KS (1996) Alpha-helical CRF blocks differential influence on corticotropin-releasing factor (CRF) on appetitive and aversive memory retrieval in rats. J Neural Transm 103:1117-1126
31. Lee EH, Sung YJ (1989) Differential influences of corticotropin-releasing factor on memory retention of aversive learning and appetitive learning in rats. Behav Neural Biol 52:285-294
32. Lu L, Ceng X, Huang M (2000) Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats. Neuroreport 11:2373-2378
33. Lu L, Liu D, Ceng X (2001) Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur J Pharmacol 415:203-208
34. Matta SG, Valentine JD, Sharp BM (1997) Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain. Endocrine 7:245-253
35. Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF (1994) Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 269:564-572
36. Netter P, Hennig J, Huwe S, Olbrich R (1998) Personality related effects of nicotine, mode of application, and expectancies on performance, emotional states, and desire for smoking. Psychopharmacology 135:52-62
37. Okuda H, Shioda S, Nakai Y, Nakayama H, Okamoto M, Nakashima T (1993) The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat. Neurosci Lett 161:183-186
38. Orleans CT (1985) Understanding and promoting smoking cessation: overview and guidelines for physician intervention. Ann Rev Med 36:51-61
39. Ouagazzal AM, Kenny PJ, File SE (1999a) Modulation of anxiety on trials 1 and 2 in the elevated plus-maze after systemic and hippocampal administration of nicotine. Psychopharmacology 144:54-60
40. Ouagazzal AM, Kenny PJ, File SE (1999b) Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety Eur J Neurosci 11:3957-3962
41. Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin releasing factor. Pharmacol Rev 43:425-473
42. Paxinos G, Watson CH (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
43. Radulovic J, Rühmann A, Liepold A, Spiess J (1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 19:5016-5025
44. Risinger FO, Oakes RA (1995) Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol Biochem Behav 51:457-461
45. Rivier J, Rivier C, Vale W (1982) Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science 218:377-379
46. Rivier J, Rivier C, Vale W (1984) Synthetic competitive antagonist of corticotropin-releasing factor: effect on ACTH secretion in the rat. Science 224:889-891
47. Sarnyay Z, Biro E, Penke B, Telegdy G (1992) The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats. Brain Res 589:154-156
48. Smart D, Copell A, Rossant C, Hall M, McKnight AT (1999) Characterisation using microphysiometry of CRF receptor pharmacology. Eur J Pharmacol 379:229-235
49. Tucci S, Cheeta S, Genn R, Seth P, File SE (2003) Anxiety conditioned to nicotine in the elevated plus-maze is time-dependent. Behav Pharmacol 13:615-620
50. Walter S, Kuschinsky K (1989) Conditioning of nicotine effects on motility and behaviour in rats. Naunyn Schmiedebergs Arch Pharmacol 339:208-213
51. 1A receptors inhibit adrenocortical secretion. Neuroendocrinology 57:272-281